+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Insomnia Drugs Market - Global Forecast 2026-2032- Product Image
Insomnia Drugs Market - Global Forecast 2026-2032- Product Image
New

Insomnia Drugs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5889526
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The insomnia drugs market is being reshaped by both breakthrough drug classes and digital technologies, as pharmaceutical companies and healthcare stakeholders shift strategies to meet evolving treatment demands, regulatory expectations, and commercial pressures.

Market Snapshot: Insomnia Drugs Market Growth and Outlook

The Insomnia Drugs Market expanded from USD 3.24 billion in 2025 to USD 3.43 billion in 2026, and is projected to achieve a compound annual growth rate (CAGR) of 5.96%, reaching USD 4.87 billion by 2032. Market advancement is driven by scientific progress in sleep medicine, greater acknowledgment of sleep as a pillar of health, and payers’ increased scrutiny of drug safety and real-world efficacy over the long term. Shifting payor expectations are compelling manufacturers to demonstrate measurable outcomes and value as insomnia treatments become an integral component of chronic care strategies.

Scope & Segmentation

  • Drug Classes: Includes antihistamines, benzodiazepines, melatonin receptor agonists, non-benzodiazepines, and orexin receptor antagonists, each targeting specific patient profiles and treatment nuances from rapid onset to prolonged effect and daytime functionality.
  • Formulation Options: Capsules, injectables, oral suspensions, sublingual tablets, and tablets offer flexibility in dosing speed, patient convenience, and alignment with varied care environments.
  • Routes of Administration: Oral, sublingual, intravenous, and transdermal routes accommodate chronic use and acute interventions, influencing clinician prescribing habits and patient preferences.
  • Distribution Channels: Drug stores, hospital pharmacies (both public and private), online pharmaceutical platforms, and retail outlets enable versatile market access and support differentiated pricing models.
  • End-User Settings: Ambulatory care, hospitals, clinics, and home care settings shape product adoption, as organizational priorities and workflow adaptations impact the procurement and prescription of therapies.
  • Regions Covered: Americas, Europe, Middle East & Africa, and Asia-Pacific are evaluated, considering differences in digital health adoption, degree of pharmaceutical localization, and sophistication of regulatory frameworks that underpin regional sales strategies.
  • Key Technologies: Digital therapeutics, remote monitoring solutions, and next-generation delivery systems are being incorporated, enhancing integration with behavioral interventions and improving adherence outcomes.

Insomnia Drugs Market: Key Takeaways

  • Mechanistic innovation is changing clinical selection, with newer orexin receptor antagonists and refined non-benzodiazepine therapies prioritizing patient safety and cognitive function.
  • Expanded formulation types and alternative administration routes are improving patient adherence and convenience, enabling customization for different treatment settings and supporting robust real-world outcomes.
  • Blending digital therapeutics and behavioral approaches with pharmacological solutions is fostering patient-centered, multi-modal insomnia management pathways and broadening the evidence base for payers.
  • Regulatory and reimbursement environments are prioritizing comprehensive outcome evidence, requiring market players to invest in post-launch data generation and value-based contracting strategies.
  • Regional and channel-specific tactics are critical as differing regulatory requirements, reimbursement policies, and digital infrastructure maturity affect uptake and market reach, particularly across Asia-Pacific and Europe.
  • Strategic alliances with digital health and supply chain partners are guiding differentiation and operational adaptability, allowing for faster responses to disruptive market changes.

Tariff Impact on Market Dynamics

Recent United States tariff measures implemented in 2025 are placing upward pressure on costs for insomnia drug manufacturers relying on imported components or finished products. These increased landed costs have prompted a re-evaluation of supplier agreements, production decisions, and pricing approaches. In response, companies are embracing multi-sourcing, expanding supplier networks, and entering long-term contracts to manage uncertainty around trade policy shifts. This dynamic is also fueling consideration of onshore or nearshore manufacturing and greater channel selectivity, particularly among branded and generic producers seeking stability and sustained margins in a volatile environment. The impact of tariff policies is uneven, necessitating scenario planning and flexible operational strategies across the sector.

Methodology & Data Sources

This report leverages a comprehensive mixed-methods approach, integrating analysis of regulatory filings, peer-reviewed scientific literature, and clinical trial data with insights from expert interviews. On-the-ground perspectives from manufacturing and supply chain professionals, as well as independent scenario validation and cross-regional comparisons, underpin all conclusions and recommendations.

Why This Report Matters

  • Presents actionable analysis of scientific advances, policy developments, and operational trends shaping the future of insomnia drug therapeutics.
  • Supports decision-makers in refining market-entry, partnership, and commercialization strategies to maximize value capture amid uncertain trade and regulatory climates.
  • Provides frameworks for benchmarking portfolio optimization and contracting choices across both established and emerging geographies and channels.

Conclusion

Enduring success in the insomnia drugs market requires a balance of therapeutic innovation, operational flexibility, and robust evidence generation. Proactive navigation of policy and technology changes helps healthcare organizations expand patient access and deliver lasting business value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Insomnia Drugs Market, by Drug Class
8.1. Antihistamines
8.2. Benzodiazepines
8.3. Melatonin Receptor Agonists
8.4. Non-Benzodiazepines
8.4.1. Eszopiclone
8.4.2. Zaleplon
8.4.3. Zolpidem
8.5. Orexin Receptor Antagonists
8.5.1. Daridorexant
8.5.2. Lemborexant
8.5.3. Suvorexant
9. Insomnia Drugs Market, by Formulation
9.1. Capsules
9.2. Injectables
9.3. Oral Suspensions
9.4. Sublingual Tablets
9.5. Tablets
10. Insomnia Drugs Market, by Route Of Administration
10.1. Intravenous
10.2. Oral
10.3. Sublingual
10.4. Transdermal
11. Insomnia Drugs Market, by End User
11.1. Ambulatory Care Centers
11.2. Clinics
11.3. Home Care
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Insomnia Drugs Market, by Distribution Channel
12.1. Drug Stores
12.2. Hospital Pharmacies
12.2.1. Private Hospitals
12.2.2. Public Hospitals
12.3. Online Pharmacies
12.3.1. General B2C Platforms
12.3.2. Manufacturer Direct Sites
12.3.3. Telepharmacy Services
12.4. Retail Pharmacies
12.4.1. Chain Pharmacies
12.4.2. Independent Pharmacies
12.4.3. Supermarket Pharmacies
13. Insomnia Drugs Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Insomnia Drugs Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Insomnia Drugs Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Insomnia Drugs Market
17. China Insomnia Drugs Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Alembic Pharmaceuticals Limited
18.6. Astellas Pharma Inc.
18.7. Aurobindo Pharma Limited
18.8. Biogen SA
18.9. Cadila Healthcare Ltd.
18.10. Dr.Reddy’s Laboratories Limited
18.11. Eisai Co., Ltd.
18.12. Eli Lilly and Company
18.13. Flynn Pharma Limited
18.14. Glenmark Pharmaceuticals Ltd.
18.15. Idorsia Pharmaceuticals Ltd.
18.16. LA Herbal (India)
18.17. Mallinckrodt Pharmaceuticals
18.18. Merck & Co., Inc.
18.19. Minerva Neurosciences, Inc.
18.20. Neuracle Lifesciences Private Limited
18.21. Neurim Pharmaceuticals LTD.
18.22. Orexo AB
18.23. Pfizer Inc.
18.24. Purdue Pharma L.P.
18.25. Sanofi Group
18.26. Sun Pharmaceutical Industries Limited
18.27. Takeda Pharmaceutical Company Limited
18.28. Vanda Pharmaceuticals Inc.
18.29. Wockhardt Limited
List of Figures
FIGURE 1. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL INSOMNIA DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL INSOMNIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES INSOMNIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA INSOMNIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY BENZODIAZEPINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY BENZODIAZEPINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MELATONIN RECEPTOR AGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MELATONIN RECEPTOR AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MELATONIN RECEPTOR AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ESZOPICLONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ESZOPICLONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ESZOPICLONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZALEPLON, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZALEPLON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZALEPLON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZOLPIDEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZOLPIDEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZOLPIDEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DARIDOREXANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DARIDOREXANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DARIDOREXANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY LEMBOREXANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY LEMBOREXANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY LEMBOREXANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUVOREXANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUVOREXANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUVOREXANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL SUSPENSIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL SUSPENSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY GENERAL B2C PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY GENERAL B2C PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY GENERAL B2C PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT SITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT SITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT SITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TELEPHARMACY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TELEPHARMACY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TELEPHARMACY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUPERMARKET PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUPERMARKET PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUPERMARKET PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 176. EUROPE INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. EUROPE INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 179. EUROPE INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 180. EUROPE INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 181. EUROPE INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 182. EUROPE INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. EUROPE INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 184. EUROPE INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. EUROPE INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 186. EUROPE INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 187. EUROPE INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 200. AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. AFRICA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 202. AFRICA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 203. AFRICA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 204. AFRICA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 205. AFRICA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 206. AFRICA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 208. AFRICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 210. AFRICA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 211. AFRICA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 225. ASEAN INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. ASEAN INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 227. ASEAN INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 228. ASEAN INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 229. ASEAN INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 230. ASEAN INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 231. ASEAN INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. ASEAN INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 233. ASEAN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 234. ASEAN INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 235. ASEAN INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 236. ASEAN INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 237. GCC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. GCC INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 239. GCC INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 240. GCC INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 241. GCC INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 242. GCC INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 243. GCC INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. GCC INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 245. GCC INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. GCC INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 247. GCC INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 248. GCC INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 261. BRICS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. BRICS INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 263. BRICS INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 264. BRICS INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 265. BRICS INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 266. BRICS INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 267. BRICS INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. BRICS INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 269. BRICS INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. BRICS INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 271. BRICS INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 272. BRICS INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 273. G7 INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. G7 INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 275. G7 INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 276. G7 INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 277. G7 INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 278. G7 INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 279. G7 INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. G7 INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 281. G7 INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 282. G7 INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 283. G7 INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 284. G7 INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 285. NATO INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. NATO INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 287. NATO INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 288. NATO INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 289. NATO INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 290. NATO INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 291. NATO INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. NATO INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 293. NATO INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 294. NATO INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 295. NATO INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 296. NATO INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 297. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 298. UNITED STATES INSOMNIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 299. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 300. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 301. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 302. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 303. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 308. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 309. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 310. CHINA INSOMNIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 311. CHINA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 312. CHINA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2032 (USD MILLION)
TABLE 313. CHINA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2032 (USD MILLION)
TABLE 314. CHINA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 315. CHINA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 316. CHINA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 317. CHINA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 318. CHINA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 319. CHINA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 320. CHINA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 321. CHINA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Insomnia Drugs market report include:
  • Alembic Pharmaceuticals Limited
  • Astellas Pharma Inc.
  • Aurobindo Pharma Limited
  • Biogen SA
  • Cadila Healthcare Ltd.
  • Dr.Reddy’s Laboratories Limited
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Flynn Pharma Limited
  • Glenmark Pharmaceuticals Ltd.
  • Idorsia Pharmaceuticals Ltd.
  • LA Herbal (India)
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Minerva Neurosciences, Inc.
  • Neuracle Lifesciences Private Limited
  • Neurim Pharmaceuticals LTD.
  • Orexo AB
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Sanofi Group
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Vanda Pharmaceuticals Inc.
  • Wockhardt Limited

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.43 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.87 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Insomnia Drug Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Insomnia Drug Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Insomnia Therapeutics Market Size, Share & Trends Analysis Report by Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), Sales Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Insomnia Therapeutics Market Size, Share & Trends Analysis Report by Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), Sales Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Insomnia Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Insomnia Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 92 Pages
  • Global
From
Insomnia Therapeutics Market 2025-2029 - Product Image

Insomnia Therapeutics Market 2025-2029

  • Report
  • 205 Pages
  • Global
From
Insomnia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Insomnia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Insomnia Drug Market

The Insomnia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Insomnia drugs are used to treat difficulty sleeping, and can be divided into two categories: sedative-hypnotics and non-sedative hypnotics. Sedative-hypnotics are drugs that act on the central nervous system to induce sleep, while non-sedative hypnotics are drugs that act on the brain to improve sleep quality without causing sedation. Commonly prescribed insomnia drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists. Some companies in the Insomnia Drug market include Sanofi, Pfizer, Merck, GlaxoSmithKline, and Takeda. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.